| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $30,788,656 ) (Continued on the next page) |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01NS120560 | SCH: Context-aware Freezing of Gait mitigation in real-world setting | 002 | 4 | NIH | 4/16/2024 | $49,228 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K08HL155852 | Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy | 000 | 4 | NIH | 11/29/2023 | $148,214 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01NS120560 | SCH: Context-aware Freezing of Gait mitigation in real-world setting | 001 | 4 | NIH | 2/22/2024 | $1 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01NS120560 | SCH: Context-aware Freezing of Gait mitigation in real-world setting | 000 | 4 | NIH | 2/21/2024 | $179,621 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HD111546 | Predictive ability of early somatosensory processing in preterm children on later motor development | 000 | 1 | NIH | 1/31/2024 | $108,675 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30AR081102 | Extracellular Matrix Vesicles and Intercellular Communication of Osteoblast-lineage Cells | 000 | 2 | NIH | 4/4/2024 | $44,294 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA272147 | Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms | 000 | 2 | NIH | 3/25/2024 | $567,162 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA272147 | Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms | 001 | 2 | NIH | 4/16/2024 | $31,509 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21AA029518 | Atypical sphingolipids in alcoholic liver disease | 000 | 2 | NIH | 3/12/2024 | $206,321 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32AA029975 | Cross-Species Multidisciplinary Training in Alcohol Research | 001 | 2 | NIH | 3/15/2024 | $389,184 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23HL159270 | The Relationship of Exercise Associated Cardiac Reserve on Peak Oxygen Consumption and Frailty Measures in Individuals Undergoing Allogeneic Hematopoietic Stem Cell Transplant. | 000 | 2 | NIH | 1/29/2024 | $149,049 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA279255 | Identification of small molecule inhibitors of the DDI2 protease | 002 | 2 | NIH | 4/17/2024 | $35,348 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA279255 | Identification of small molecule inhibitors of the DDI2 protease | 001 | 2 | NIH | 4/10/2024 | $77,925 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277525 | The Role of Non-Coding RNA Editing in MET Signaling in NSCLC | 001 | 2 | NIH | 4/16/2024 | $9,376 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277525 | The Role of Non-Coding RNA Editing in MET Signaling in NSCLC | 000 | 2 | NIH | 3/1/2024 | $168,795 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA279255 | Identification of small molecule inhibitors of the DDI2 protease | 000 | 2 | NIH | 3/15/2024 | $636,295 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL168133 | Antibacterial and Antithrombotic Catheter Lock Solutions Based on Controlled Release of Nitric Oxide | 000 | 2 | NIH | 2/9/2024 | $388,125 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AG082251 | Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study | 000 | 2 | NIH | 3/8/2024 | $564,599 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31DK135372 | The role of sphingosine kinase 2 in mitochondrial dysfunction and NAFLD | 000 | 2 | NIH | 4/17/2024 | $41,294 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30MD018324 | The relationship between social needs and primary care use after enrollment in Virginia?s Medicaid expansion: The influence of sociocultural and built environments | 002 | 2 | NIH | 11/6/2023 | $40,689 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL162991 | Metabolic perturbations in conventional dendritic cells modulate Tfh13 induction in asthmatic sensitization | 000 | 2 | NIH | 11/13/2023 | $545,820 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R61CA278445 | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | 000 | 2 | NIH | 3/25/2024 | $189,927 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R61CA278445 | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | 001 | 2 | NIH | 4/16/2024 | $10,552 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R25DA058484 | Equipping social workers on the front line: The child welfare and addiction specialist fellowship program | 000 | 2 | NIH | 1/25/2024 | $220,813 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA055825 | Pharmacology of Stimulant Choice | 000 | 2 | NIH | 2/23/2024 | $314,381 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01NS124974 | Trial Readiness and Endpoint Assessment in LGMDR1 (TREATing-LGMDR1) | 000 | 2 | NIH | 3/7/2024 | $876,664 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA267971 | Novel inhibitors of oncogenic p53 mutants for lung cancer therapy. | 000 | 2 | NIH | 11/30/2023 | $163,304 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277518 | Role of the DREAM complex in the lung tumor suppression | 001 | 2 | NIH | 4/16/2024 | $9,072 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277518 | Role of the DREAM complex in the lung tumor suppression | 000 | 2 | NIH | 1/10/2024 | $163,304 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI174301 | Lentivirus-like particle specific delivery of Cas12 ribonucleoprotein (RNP) to HIV reservoir cells in vivo for an HIV cure | 001 | 2 | NIH | 2/16/2024 | $786,908 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32GM148403 | VCU Initiative for Maximizing Student Development Program (IMSD) | 000 | 2 | NIH | 1/16/2024 | $262,663 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL163101 | Protein S-Palmitoylation in the Heart: Function and Regulation in Health and Disease | 000 | 2 | NIH | 11/15/2023 | $373,062 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 001 | 4 | NIH | 1/4/2024 | $1,301,065 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 002 | 4 | NIH | 2/1/2024 | $1,301,065 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 002 | 4 | NIH | 2/1/2024 | -$1,301,065 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AI169840 | PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease | 000 | 2 | NIH | 10/23/2023 | $607,136 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K01MH131847 | Genetic architecture of transdiagnostic psychosis symptom dimensions | 000 | 2 | NIH | 12/15/2023 | $160,170 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32GM144294 | VCU Medical Scientist Training Program | 000 | 3 | NIH | 4/9/2024 | $276,519 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259415 | Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma | 001 | 2 | NIH | 4/17/2024 | $20,880 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259415 | Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma | 000 | 2 | NIH | 12/15/2023 | $375,845 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH125902 | An Integrative Approach to the Etiology of Internalizing Disorders in the Lifelines Cohort | 000 | 3 | NIH | 10/31/2023 | $511,600 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM152058 | Ins and outs of the bioactive sphingolipid metabolite sphingosine-1-phosphate | 000 | 1 | NIH | 12/22/2023 | $388,125 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DE033842 | Connecting liquid-liquid phase separation with super-enhancers and key oncogene transcription in HNSCC | 000 | 1 | NIH | 2/20/2024 | $228,185 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31MH134546 | Neurodevelopmental Trajectories as an Explanatory Mechanism for Adverse Mental Health Outcomes following Child Maltreatment | 001 | 1 | NIH | 3/1/2024 | $0 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31MH134546 | Neurodevelopmental Trajectories as an Explanatory Mechanism for Adverse Mental Health Outcomes following Child Maltreatment | 000 | 1 | NIH | 3/1/2024 | $41,649 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23MH134111 | Using youth-engaged methods to develop and evaluate a measure for disordered eating behaviors in transgender and gender-diverse youth | 000 | 1 | NIH | 3/15/2024 | $205,308 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI183749 | Anaplasma phagocytophilum exploitation of regulated exocytosis. | 000 | 1 | NIH | 4/9/2024 | $68,684 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31CA290944 | Elacestrant in breast cancer bone metastases | 000 | 1 | NIH | 4/1/2024 | $42,124 |
| | 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA285692 | MYCN drives a druggable SUMOylation program in neuroblastoma | 000 | 1 | NIH | 12/27/2023 | $434,312 |
|
